While presenting this year’s Nobel Prize in Physiology or Medicine to three immunologists who discovered and characterized regulatory T cells, committee chair Olle Kämpe, M.D., Ph.D., told the ...
In 2006 immunologist and 2025 Nobel prize winner Shimon Sakaguchi co-wrote an article in Scientific American that now feels prophetic. In the story, entitled “Peacekeepers of the Immune System,” ...
It looks like a magic trick: Cells at the bottom of a liquid medium begin levitating, then hovering at a particular height. With no physical contact, an invisible force directs certain cells to float ...
Breastfeeding has long been linked to a reduced risk of breast cancer, but how it has this effect isn’t entirely clear. Now, scientists have found that women who have breastfed have more specialised ...
Weekend mornings anchor, CBS New York; Correspondent, CBS News and Stations Elaine Quijano is a weekend mornings anchor for CBS New York and a correspondent for CBS News and Stations, contributing to ...
How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs
Cancer treatment has come a long way, but many of today's therapies still come with steep costs: not just financial, but physical and emotional too. Chemotherapy and radiotherapy remain vital tools, ...
Scientists have found a new way to stop cancer growth without damaging healthy cells. Researchers from the Francis Crick Institute and Vividion Therapeutics discovered a compound that blocks the ...
Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic editing platform that enables safe modification of multiple genes in primary ...
Pregnancy and breastfeeding induces the accumulation of specialized immune cells that reduce the chances of breast cancer developing, finds a study 1 in humans and mice that is published in Nature ...
A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in the lab. Built from patient-derived stem cells and immune cells, it ...
In Alzheimer's, brain cells die too soon. In cancer, dangerous cells don't die soon enough. That's because both diseases alter the way cells decide when to end their lives, a process called programmed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback